Buys
Open market- Shares
- Avg price
- Total value
Scott L. Burrows - Chief Financial Officer at Spyre Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Financial Officer
- Issuer Symbol
- SYRE on Nasdaq
- All Insider Reports
- All Insider Reports
Scott L. Burrows - trading volume in the past year for Spyre Therapeutics, Inc.
Sells
Open market- Shares
- -40,928
- Avg price
- $40.64
- Total value
- -$1,663,460
Net
Past year- Shares
- -40,928
- Share %
- -100%
- Total value
- -$1,663,460
Holdings reported by Scott L. Burrows for Spyre Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Spyre Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 97,994
- Estimated value
- $6,993,831
- Report date
- 01 May 2026
- Price
- $71.37
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Spyre Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 382,357
- Estimated value
- Report date
- 01 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Scott L. Burrows for Spyre Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.